Novartis Ag (NVS) Other Non Operating Income (2009 - 2026)

Novartis Ag has reported Other Non Operating Income for 18 years, with the latest figure at -$17.0 million in Q2 2026.

• Quarterly Other Non Operating Income rose 58.54% year-over-year to -$17.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$179.0 million (down 264.22% YoY) and the FY2025 annual result came in at -$136.0 million, down 197.14% from the prior year.
• Other Non Operating Income improved to -$17.0 million in Q2 2026 per NVS's latest filing, from -$50.0 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $204.0 million in Q4 2023 and troughed at -$92.0 million in Q4 2025.
• A 5-year average of $25.7 million and a median of $16.5 million in 2022 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2023 and 2026: Other Non Operating Income jumped 466.67% in 2023, then slumped 394.12% in 2026.
• Over 5 years, Other Non Operating Income stood at $36.0 million in 2022, then surged by 466.67% to $204.0 million in 2023, then slumped by 47.55% to $107.0 million in 2024, then plunged by 185.98% to -$92.0 million in 2025, then jumped by 81.52% to -$17.0 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$17.0 million, -$50.0 million, and -$92.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.